- Leadership - Novavax
Silvia Taylor Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden
- Novavax - Wikipedia
In April 2025, Novavax was still in the process of obtaining full licensure for its COVID-19 vaccine, having submitted a Biologics License Application to the FDA, who requested Novavax complete an additional clinical trial
- Two Years Into Novavax Reset, CEO Jacobs Hunts for Silver Linings
After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs says the company is at a pivot point In February 2023, Novavax warned investors that it might not be able to continue operations for another year
- John C. Jacobs - Novavax | LinkedIn
Experience: Novavax · Location: Greater Philadelphia · 500+ connections on LinkedIn View John C Jacobs’ profile on LinkedIn, a professional community of 1 billion members
- Novavax Names John C. Jacobs as New President Chief Executive Officer . . .
Novavax Names John C Jacobs as New President Chief Executive Officer Current President CEO Stanley C Erck will retire effective January 23 with plans to support the leadership transition in an advisory capacity
- Novavax CEO John Jacobs is refocusing the biotech for a new era . . .
The turnaround man John Jacobs is reshaping Novavax for the post-pandemic era “We may surprise people with where we’re headed,” says John Jacobs, the CEO of Gaithersburg biotech Novavax
- NVAX | Novavax Inc. Company Profile Executives - WSJ
Company profile for Novavax Inc including key executives, insider trading, ownership, revenue and average growth rates View detailed NVAX description address
- Novavax CEO and Key Executive Team - Craft. co
Novavax's Director, President and Chief Executive Officer is Stanley C Erck Other executives include Frank Czworka, Senior Vice President, Global Sales, Trade Distribution; Rick Crowley, Executive Vice President, Chief Operations Officer and 27 others See the full leadership team at Craft
|